Respiratory Medicine
Pharmacology of salmeterol delivered by non-CFC inhalers determined
Published in Clinical Trials Week, June 6th, 2005
Scientists in England conducted a "randomized, double-blind, placebo-control led, cross-over study comparing the systemic pharmacodynamic effects (heart rate and serum potassium) and pharmacokinetics of salmeterol delivered by the non-CFC hydrofluoralkane (HFA) propellant 134a and the CFC propellant (propellant 11/12) metered dose inhalers (MDI) in healthy subjects."
"At the therapeutic dose (50 microg), salmeterol-mediated systemic pharmacodynamics were equivalent for the HFA and CFC MDIs," R. Kempsford and coauthors at GlaxoSmithKline Research & Development found....
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Trials Week
Source: Clinical Trials Week (2005-06-06)
More Articles from Clinical Trials Week
- Acute Maxillary Sinusitis
Five-day telithromycin therapy safe and effective - Anti-Infectives
Probiotics prevent antibiotic-associated diarrhea in infants - Cancer Therapy
Ixabepilone shows promise in phase I clinical trial - Post-Traumatic Stress Disorder
Cognitive therapy significantly ameliorates PTSD symptoms - Acute Bacterial Conjunctivitis
Gatifloxacin 0.3% BID safe and effective in clinical trial - Acute Lymphoblastic Leukemia
Company initiates phase I/II clinical trial of talotrexin in patients with ALL - More from this issue of Clinical Trials Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
